MENU
ALRN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Aileron Therapeutics (ALRN) Ownership - Who owns Aileron Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
285 Summer Street
Phone
+1 617 995-0900
Employees
6
Web
https://www.aileronrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
79.08M
P/E Ratio
N/A
Total Cash
21.92M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.85
Dividend Yield
N/A
Total Cash/Share
1.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALRN
Capitalization
79.1M
P/E Ratio
N/A
Risk (Beta)
1.85
Dividend Yield
N/A
Total Cash
21.9M
Total Cash/Share
1.01
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
56M
P/B Ratio
1.41
Cash Flow
N/A
Earnings
-3.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
107K
Current Ratio
4.69
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-25.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.88
Shares Held By Institutions
13.8M
Shares Outstanding - Current
21.7M
Total Liabilities
53.4M
Total Volume MTD
N/A
Value
1
Gain YTD
20.383
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of stapled peptide drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
285 Summer Street
Phone
+1 617 995-0900
Employees
6
Web
https://www.aileronrx.com